Goldman Sachs’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.16M | Buy |
|
|||||
|
2025
Q2 | $5.72M | Sell |
|
|||||
|
2025
Q1 | $7.91M | Sell |
|
|||||
|
2024
Q4 | $14M | Buy |
|
|||||
|
2024
Q3 | $10.1M | Buy |
|
|||||
|
2024
Q2 | $8.03M | Buy |
|
|||||
|
2024
Q1 | $8.94M | Sell |
|
|||||
|
2023
Q4 | $11.8M | Buy |
|
|||||
|
2023
Q3 | $5.09M | Buy |
|
|||||
|
2023
Q2 | $4.31M | Buy |
|
|||||
|
2023
Q1 | $3.57M | Sell |
|
|||||
|
2022
Q4 | $4.49M | Buy |
|
|||||
|
2022
Q3 | $3.81M | Buy |
|
|||||
|
2022
Q2 | $1.6M | Sell |
|
|||||
|
2022
Q1 | $1.5M | Buy |
|
|||||
|
2021
Q4 | $2.12M | Buy |
|
|||||
|
2021
Q3 | $429K | Buy |
|
|||||
|
2021
Q2 | $402K | Buy |
|